Prochymal™ Clinical Trial Information for the Treatment of Crohn's Disease

Crohn's disease is a chronic, life-long condition with relapsing inflammation of the bowels and gastrointenstinal tract. Its fundamental cause is unknown, but it is suspected to come from a genetic predisposition of the body’s overreaction to the environment, items in the diet, or an infection. Severe Crohn's disease can cause pain, undesirable changes in lifestyle, hospitalizations, and side-effects from medications used for treatment. While Crohn's disease often first occurs in people between the ages of 20 and 30, it can occur in children or at any other age. In the majority of sufferers, it requires surgery at least once. Over 500,000 people in the U.S. are afflicted with Crohn's disease, and approximately 20,000 new cases are diagnosed each year.

Your Options

It is vitally important that we continue to find new effective ways to treat individuals who develop Crohn's disease. By participating in clinical trials, you can make an invaluable contribution to others experiencing Crohn's disease.

Phase III trial is currently enrolling patients

Phase II results of Crohn's disease trial